FDA recommendations on BE trials during the pandemic [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-04-28 23:01 (628 d 19:16 ago) – Posting: # 21358
Views: 2,660

Dear all,

The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence.

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,829 posts in 4,566 threads, 1,555 registered users;
online 14 (0 registered, 14 guests [including 6 identified bots]).
Forum time: Monday 17:18 CET (Europe/Vienna)

Discovery consists of seeing what everybody has seen
and thinking what nobody has thought.    Albert Szent-Györgyi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5